Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Constance CareWAR:CCR 20 Equity-to-Asset is -0.42 as of Jun. 2026. GuruFocus rates WAR:CCR with a GF Score™ of 20/100 and a GF Value™ of zł0.15 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 687 Healthcare Providers & Services companies, Constance Care ranks worse than 94.47% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Constance Care's Total Stockholders Equity for the quarter that ended in Jun. 2026 was zł-5.26 Mil. Constance Care's Total Assets for the quarter that ended in Jun. 2026 was zł12.52 Mil.
The historical rank and industry rank for Constance Care's Equity-to-Asset or its related term are showing as below:
WAR:CCR'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.42 Med: 0.15 Max: 0.29
Current: -0.42
During the past 6 years, the highest Equity to Asset Ratio of Constance Care was 0.29. The lowest was -0.42. And the median was 0.15.
WAR:CCR's Equity-to-Asset is ranked worse than 94.47% of 687
companies
in the Healthcare Providers & Services industry
Industry Median: 0.49
vs WAR:CCR: -0.42
Constance Care (WAR:CCR) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Constance Care Equity-to-Asset Related Terms
Constance Care Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Constance Care's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:CCR vs HCA, THC, EHC: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Constance Care's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Constance Care Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Constance Care's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Constance Care's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Constance Care's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Constance Care (WAR:CCR) has a Equity-to-Asset of -0.42 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Constance Care and its competitors. According to the industry distribution chart, Constance Care ranks #649 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 94.5%.
Is Constance Care's Equity-to-Asset too high?
Constance Care's current Equity-to-Asset is -0.42. Based on the distribution chart, Constance Care ranks #649 out of 687 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Constance Care has a GF Score™ of 20/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Constance Care's Equity-to-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Constance Care ranks #649 out of 687 companies for Equity-to-Asset. This places Constance Care in the lower half of its industry. The industry median Equity-to-Asset is 0.49. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.49, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Constance Care and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Constance Care's current Equity-to-Asset is -0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Constance Care stock overvalued right now?
Based on GuruFocus' analysis, Constance Care (WAR:CCR) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.15, compared to a current price of zł8.50 — trading 5566.7% above its estimated fair value. The current Equity-to-Asset is -0.42. Constance Care's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Constance Care (WAR:CCR), the current Equity-to-Asset is -0.42 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Constance Care (WAR:CCR) Overvalued in 2026?
Based on GuruFocus' analysis, Constance Care stock appears to be overvalued.
The current stock price of zł8.50 is trading 5566.7% above its estimated GF Value™ of zł0.15.
GuruFocus considers Constance Care to be Significantly Overvalued.
Key valuation signals for WAR:CCR:
Equity-to-Asset: -0.42
GF Value™: zł0.15 vs. price of zł8.50 (5566.7% above fair value)
No single metric tells the full story. See the WAR:CCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Constance Care SA conducts physiotherapeutic activities aimed at improving the quality of health and life of people suffering both from musculoskeletal disorders as a result of various random events, diseases or related to the aging of the body, as well as the rehabilitation of cognitive functions in children and adults.
20GF Score
Get the complete analysis for WAR:CCR
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:CCR has been successfully added to your 
